BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34402476)

  • 1. Prediction of high-risk esophageal varices in patients with compensated cirrhosis using albumin-bilirubin-platelet score.
    Abd Elbaser ES; Sharaf AL; Farag AA
    Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):332-337. PubMed ID: 34402476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VariScreen secures the screening of high-risk varices in patients with hepatitis B virus-related cirrhosis beyond Baveno VI criteria.
    Tan M; Zhang W; Zhou H; Liu Y; Lu T; Zhang Y; Li C; Yang Y; Wu Y; Hu H; Li Y; Yang F; Lin S
    Front Physiol; 2022; 13():1006657. PubMed ID: 36237519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
    Stafylidou M; Paschos P; Katsoula A; Malandris K; Ioakim K; Bekiari E; Haidich AB; Akriviadis E; Tsapas A
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1744-1755.e11. PubMed ID: 31077823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combination of Shear Wave Elastography and Platelet Counts Can Effectively Predict High-Risk Varices in Patients with Hepatitis B-Related Cirrhosis.
    Xie X; Feng Y; Lyu Z; Wang L; Yang Y; Bai Y; Liu C; Wu H; Ren W; Zhu Q
    Biomed Res Int; 2021; 2021():6635963. PubMed ID: 33928154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Patients With Cirrhosis Who Might Avoid Screening Endoscopy Based on Serum Albumin and Bilirubin and Platelet Counts.
    Kew GS; Chen ZJ; Yip AW; Huang YWC; Tan LY; Dan YY; Gowans M; Huang DQ; Lee GH; Lee YM; Lim SG; Low HC; Muthiah MD; Tai BC; Tan PS
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):199-201.e2. PubMed ID: 31712081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis.
    Zhao L; Wang T; Guo C; Zhou L; Han P; Wang C; Ma Y; Wang J; Gao M; Li J
    Hepatol Int; 2022 Aug; 16(4):936-943. PubMed ID: 35727500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].
    Xu HF; Wang Y; He FL; Fan ZH; Liu H; Yang YP; Jia JD; Liu FQ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1092-1099. PubMed ID: 36727234
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation of the EVendo score for the prediction of varices in cirrhotic patients.
    Alswat K; Alanazi M; Bashmail A; Alkhamash M; Alqahtani SA; Al-Hamoudi W; Abdo AA
    Saudi J Gastroenterol; 2022; 28(5):378-384. PubMed ID: 35229755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
    Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
    Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
    Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
    Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
    Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Yan Y; Xing X; Wang X; Yang L
    Eur Radiol; 2022 Mar; 32(3):2078-2088. PubMed ID: 34713329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Baveno VI Criteria for Screening of Esophageal Varices in a Cohort of South Asian Patients with Compensated Chronic Liver Disease.
    Tadkalkar V; Devadas K; Varghese J; Cyriac R
    J Assoc Physicians India; 2020 Oct; 68(10):24-28. PubMed ID: 32978921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.